SuperworthBausch & Lomb profit margin BLCO
Gross, operating and net profit as a share of revenue over the last twelve months, from 2021.
- Net margin, 12 months
- −3.2%
- Operating margin, 12 months
- 6.1%
- Net margin on a year earlier
- +2.4 pts
- Peer median
- 10.7%
Over the twelve months to Jun 30, 2026, Bausch & Lomb kept −3.2% of its revenue as net profit, with an operating margin of 6.1% and a gross margin of 61.4%.
The median for 10 medical instruments and supplies stocks of a similar size is 10.7%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −7.1% | 2.2% | 59.8% |
| FY2024 | −6.6% | 3.4% | 60.9% |
| FY2023 | −6.3% | 3.1% | 60.4% |
| FY2022 | 0.2% | 5.5% | 59.7% |
| FY2021 | 4.8% | 8.7% | 61.0% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −3.2% | +2.4 pts | 6.1% | |
| Q1 FY26 | −4.2% | +3.3 pts | 4.4% | |
| Q4 FY25 | −7.1% | −0.4 pts | 2.2% | |
| Q3 FY25 | −6.1% | +1.7 pts | 1.8% | |
| Q2 FY25 | −5.6% | +4.6 pts | 0.7% | |
| Q1 FY25 | −7.5% | +0.3 pts | 1.5% | |
| Q4 FY24 | −6.6% | −0.3 pts | 3.4% | |
| Q3 FY24 | −7.9% | −2.6 pts | 2.6% | |
| Q2 FY24 | −10.1% | −6.5 pts | 2.7% | |
| Q1 FY24 | −7.8% | −5.1 pts | 3.2% | |
| Q4 FY23 | −6.3% | −6.4 pts | 3.1% | |
| Q3 FY23 | −5.2% | −6.8 pts | 3.3% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Bausch & Lomb's size, closest first, today.
| Company | Profit margin |
|---|---|
| BLCOBausch & Lomb | −3.2% |
| MMSIMerit Medical Systems | 9.2% |
| MSAMSA Safety | 16.1% |
| HAEHaemonetics | 7.1% |
| VNTVontier | 11.3% |
| BMIBadger Meter | 14.3% |
| ICUIICU Medical | 1.4% |
| NVSTEnvista | 3.3% |
| PODDInsulet | 12.3% |
| GMEDGlobus Medical | 17.0% |
| ALGNAlign Technology | 10.0% |
| Peer median | 10.7% |
Where Bausch & Lomb ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Bausch & Lomb
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.